Literature DB >> 2022978

Nuclear exercise testing and the management of coronary artery disease.

R M Steingart1, S Wassertheil-Smoller, J N Tobin, J Wexler, N Budner.   

Abstract

Three hundred seventy-eight patients referred for nuclear exercise testing were classified using demographics and symptoms into low, intermediate, and high coronary disease likelihood categories. These likelihood groups constituted 15%, 41%, and 15% of referrals, respectively. Patients with prior infarction or disease at angiography (proven disease) made up the remaining 29% of patients. Only 2% of low likelihood patients had typical angina, but physicians diagnosed coronary disease in 64%, prescribed antianginal therapy in 50%, and were considering catheterization in 28% of these patients, all as frequently as for patients with intermediate or high likelihoods for disease. Patients with proven disease were treated differently in that 79% were receiving antianginal therapy and 56% were considered for catheterization (p less than 0.001). Nuclear exercise test results reduced the perceived need for catheterization in all groups, on average by 49%. Nuclear exercise tests are a standard by which patients are managed, sometimes substituting for the traditional role of the history in physician decision making.

Entities:  

Mesh:

Year:  1991        PMID: 2022978

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  A normal stress SPECT scan is an effective gatekeeper for coronary angiography.

Authors:  Todd D Miller; David O Hodge; James J Milavetz; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

2.  Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease.

Authors:  J H O'Keefe; T M Bateman; R W Ligon; J Case; J Cullom; C Barnhart; J Spertus
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

Review 3.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

Review 4.  Prognostic value of myocardial perfusion imaging: state of the art and new developments.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

5.  The impact of clinical data on interpretation of thallium scintigrams.

Authors:  M Simons; J A Parker; K J Donohoe; J E Udelson; E V Gervino
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

6.  Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy.

Authors:  T M Bateman; J H O'Keefe; V M Dong; C Barnhart; R W Ligon
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.